AFC-HD AMS Life Science Co., Ltd. / Fundamentals

    Income statement

    Net revenue
    €183.58M
    Cost of goods sold
    €122.02M
    Gross profit
    €61.56M
    SG&A expenses
    €36.02M
    R&D expenses
    €0.00
    EBITDA
    €18.39M
    D&A
    €5.38M
    EBIT
    €12.45M
    Interest expenses
    €622.47K
    EBT
    €12.88M
    Tax expenses
    €4.18M
    Net income
    €8.49M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€8.49M
    Changes in working capital
    €0.00
    Operating cash flow
    €0.00
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €0.00
    Net financing cash flow
    €0.00
    Foreign exchange effects
    €0.00
    Net change in cash
    €0.00
    Cash at end of period
    €0.00
    Free cash flow
    €0.00

    Balance sheet

    Cash and cash equivalents
    €63.98M
    Cash and short-term investments
    €64.68M
    Total receivables
    €15.81M
    Inventory
    €37.29M
    Other current assets
    €5.57M
    Total current assets
    €123.36M
    Property, plant & equipment
    €117.14M
    Goodwill
    €12.55M
    Intangible assets
    €888.56K
    Long-term investments
    €0.00
    Other non-current assets
    €17.80M
    Total non-current assets
    €148.37M
    Total assets
    €271.73M
    Accounts payable
    €19.55M
    Short-term debt
    €56.15M
    Other current liabilities
    €11.48M
    Total current liabilities
    €96.91M
    Long-term debt
    €78.94M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €11.81M
    Total non-current liabilities
    €90.75M
    Total liabilities
    €187.65M
    Common stock
    €12.13M
    Retained earnings
    €57.80M
    Other equity
    €30.33K
    Total equity
    €84.08M
    Total liabilities and shareholders' equity
    €271.73M

    Company information

    Market capitalization
    €69.93M
    Employees
    994
    Enterprise Value
    €24.61B

    Company ratios

    Gross margin
    33.5% Better than peer group: 28.1%
    EBITDA margin
    10.0% Even with peer group: 9.3%
    EBIT margin
    6.8% Even with peer group: 6.1%
    EBT margin
    7.0% Even with peer group: 6.5%
    Net margin
    4.6% Even with peer group: 4.2%
    ROE
    10.1% Even with peer group: 12.6%
    ROA
    3.1% Even with peer group: 6.7%
    Asset turnover
    67.6% Much worse than peer group: 175.4%
    FCF margin
    0.0%
    FCF yield
    0.0%
    Efficiency ratio
    90.0%
    Net sales per employee
    €184.68K
    Net income per employee
    €8.54K

    Notifications